BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CCMG | CCGM - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CCMG | CCGM
X-ORIGINAL-URL:https://ccmg.51-222-78-205.ygkweb.ca
X-WR-CALDESC:Events for CCMG | CCGM
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230324T120000
DTEND;TZID=America/Toronto:20230324T130000
DTSTAMP:20260626T174140
CREATED:20221202T193938Z
LAST-MODIFIED:20230301T200909Z
UID:10000020-1679659200-1679662800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:CCMG Webinar - Presented by Illumina
DESCRIPTION:Detection Of Gene Fusions As Drivers For Targeted Therapies Using Rna Based Comprehensive Genomic Profiling (cgp) \nPresented by Illumina \nDescription:\nGenomic alterations known as gene fusions often drive cancer and can be important to detect across many different tumor types. Today\, targeted therapies exist for a growing number of gene fusions and have proven to be effective and safe options for patients. However\, variation in testing technologies can result in significant differences in the likelihood of fusion identification. In this session we will review the clinical actionability of known and novel driver fusions across tumor types and discuss the role of a CGP approach utilizing both DNA and RNA sequencing to accurately identify all targetable gene fusions. \nSpeaker: Erica Schnettler \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/ccmg-webinar-presented-by-illumina/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230317T110000
DTEND;TZID=America/Toronto:20230317T120000
DTSTAMP:20260626T174140
CREATED:20220902T205123Z
LAST-MODIFIED:20230310T144241Z
UID:10000005-1679050800-1679054400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf March 2023
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTitle: Approach To Mucopolysaccharidoses\nStarting with the biochemistry of glycosaminoglycans\, we will review the pathophysiology of mucopolysaccharidoses. Attendees will learn to distinguish between the various subtypes based on their clinical presentations and diagnostic test results. At the end\, we will compare the various treatment modalities available as well as strategies for the development of future treatments. \nLearning Objectives \n\n\n\n\n\n\n\nDescribe the general pathophysiology of mucopolysaccharidoses.\nDistinguish between the different subtypes of mucopolysaccharidoses.\nCompare the different treatment modalities/strategies for managing.\n\n\n\n\n\n\n\nSpeaker bio\nDr. Andrea Yu is currently a metabolic physician working at CHEO and an assistant professor at the University of Ottawa. She completed her residency in Medical Genetics and Genomics as well as her Clinical Biochemical Fellowship at the University of Ottawa. From 2018 – 2020\, she was a Clinical Geneticist and Assistant Professor at the London Health Sciences Centre/University of Western Ontario. Her academic interests include medical education and research in describing rare inborn errors of metabolism. \n  \nClick HERE to register. \n  \n  \n  \nDates \nSeptember 16 – UBC\nOctober 14 – TBD\nNovember 18 – TBD\nDecember 16 – Ottawa\nJanuary 20 – Calgary\nFebruary 17 – McGill\nMarch 17 – TBD\nApril 14 – Toronto\nMay 19 – Manitoba\nJune 16 – Montreal \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-march-2023/
CATEGORIES:TeleGraf
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230224T120000
DTEND;TZID=America/Toronto:20230224T130000
DTSTAMP:20260626T174140
CREATED:20220902T210651Z
LAST-MODIFIED:20230221T220055Z
UID:10000012-1677240000-1677243600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG - The Leading Strand Series February 2022
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nReconsidering Reproductive Carrier Screening\nA review of the tennets of reproductive carrier screening and points to provoke thought into what can be done better. A presentation of an update on advances of reproductive carrier screening. \nLearning Objectives \nConsider the rationale for carrier screening and different approaches\n– Compare the current practice in Canada vs elsewhere\n– Describe what has changed the landscape\n– Critique the pros and cons of panethnic and expanded carrier testing\n– Discuss where to go from her \nSpeakers bios \nDr. Joanna Lazier – Joanna Lazier is a Medical Geneticist at CHEO in Ottawa. She has a longstanding interest in prenatal and perinatal Genetics\, and founded the Prenatal Genetics Clinic in Edmonton. Upon moving to Ottawa in 2018\, she has become actively involved in prenatal and perinatal Genetics within the province of Ontario\, and is the chair of Prenatal Screening Ontario’s Genetics Working Group\, and the primary author of the CCMG position statement for the clinical application of fetal genome-wide sequencing during pregnancy. She is the chair of the CCMG Clinical Practice committee and co-chair of the CCMG Working Group on Reproductive Genetic Screening. \nDr. Ritu Aul – Dr. Aul is a Medical Geneticist who has been practicing in the GTA for more than 12 years. She completed her Medical Genetics residency at the University of British Columbia after medical school at Queen’s University. Dr. Aul has a special interest in prenatal screening and prenatal diagnosis. She currently sits on the CCMG Clinical Practice committee and co-chairs a working group with Dr. Lazier on updating current national guidelines for Reproductive Carrier Screening. \nDates \nSeptember 23\nOctober 28\nNovember 25\nDecember 16\nJanuary 27\nFebruary 24\nMarch 31\nApril 28\nMay 26\nJune 30 \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-february-2022/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230217T110000
DTEND;TZID=America/Toronto:20230217T120000
DTSTAMP:20260626T174140
CREATED:20220902T205029Z
LAST-MODIFIED:20230213T155935Z
UID:10000004-1676631600-1676635200@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf February 2023
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nZellweger Spectrum Disorders (ZSD) – Evolving Clinical\, Biochemical and Molecular Heterogeneity\nStarting form basic peroxisome biology and biochemistry\, we will review peroxisome assembly and contributions to the cellular and tissue milieu. The clinical phenotypes of Zellweger Spectrum Disorder will be discussed\, from severe to mild. Atypical and novel phentoypes will be presented. Potential underlying moleclar mechanisms that might explain phenotype severity will be reviewed. Finally\, diagnostic approaches and challenges for therapy will be presented. \nLearning Objectives: \n\nDescribe the heterogeneity in Zellweger Spectrum disorders\nIntegrate newly described phenotypes\nFormulate a diagnostic model for peroxisome disorders\n\nSpeaker\n \nDr. Nancy Braverman\nBio \nDr. Nancy Braverman is currently Professor of the Departments of Pediatrics and Human Genetics at McGill University\, attending clinical and biochemical geneticist at the McGill University Health Center (MUHC)\, and Senior Scientist at the Research Institute of the MUHC. Prior to January 2008\, her appointment was at Johns Hopkins University School of Medicine where she was Assistant Professor of the Department of Pediatrics and the McKusick-Nathans Institute of Genetic Medicine. She is a member of professional societies including the Garrod Association\, the American College of Medical Genetics\, the Society for Inborn Errors of Metabolism\, the Society for the Study of Inborn Errors of Metabolism\, and the American Society of Human Genetics. She is currently Chair of the ClinGen expert panel on variant curation in peroxisome disorders (2019- present)\, Advisory Board member of the Journal of Inherited Metabolic Disease (2016-present) and previously served as Chair of the Therapeutics Committee of the American College of Medical Genetics (2017-2019)\, member of the Board of Directors of the Society for Inborn Errors of Metabolism (2009-2014)\, member of the New York Mid-Atlantic Consortium for Genetic and Newborn Screening Services (2007-2009). She received her MSc in Genetic Counseling at Sarah Lawrence College\, her MD degree from Tulane University School of Medicine\, did her pediatrics residency at Yale-New Haven Hospital\, pediatrics chief residency at Sinai Hospital of Baltimore\, and her genetics fellowship at Johns Hopkins Medical Center. She has authored more than 120 peer-reviewed publications and six book chapters\, including peroxisomal disorders in Rudolph’s Pediatrics. As a clinician-scientist\, she has dedicated her career to the study of Peroxisome Biogenesis Disorders\, initially identifying the disease genes\, characterizing the mutation spectrum\, generating novel mouse models to study disease pathophysiology and trial candidate therapies. She has been recognized with multiple research and teaching awards.  \nDates \nSeptember 16 – UBC\nOctober 14 – TBD\nNovember 18 – TBD\nDecember 16 – Ottawa\nJanuary 20 – Calgary\nFebruary 17 – McGill\nMarch 17 – TBD\nApril 14 – Toronto\nMay 19 – Manitoba\nJune 16 – Montreal \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-february-2023/
CATEGORIES:TeleGraf
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230127T120000
DTEND;TZID=America/Toronto:20230127T130000
DTSTAMP:20260626T174140
CREATED:20220902T210601Z
LAST-MODIFIED:20230125T221946Z
UID:10000011-1674820800-1674824400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG - The Leading Strand Series January 2023
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nJanuary 27\, 2023 – New Adventures in Neurogenetics \nDr. James Dowling\, Senior Scientist\, Program of Genetics and Genome Biology\nThe Hospital for Sick Children\nStaff Clinician\, Division of Neurology\, The Hospital for Sick Children\nProfessor\, Departments of Paediatrics and Molecular Genetics\, University of Toronto \n  \n  \n  \n  \n  \nDates \nSeptember 23\nOctober 28\nNovember 25\nDecember 16\nJanuary 27\nFebruary 24\nMarch 31\nApril 28\nMay 26\nJune 30 \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-january-2023/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230120T110000
DTEND;TZID=America/Toronto:20230120T120000
DTSTAMP:20260626T174140
CREATED:20220902T204931Z
LAST-MODIFIED:20230117T202443Z
UID:10000003-1674212400-1674216000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf January 2023
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nJanuary 20th – Inborn Errors Of Metabolism In Adults: Challenges And Opportunities In An Emerging Distinct Population \nAdvances in the diagnosis and treatment of inborn errors of metabolism have resulted in an emerging population of adult\npatients who face unique challenges in diagnosis\, management and transition to adult care. Approaching these patients as a\ndistinct population can provide a foundation for further research\, and facilitate improvements in the care of adult metabolic\npatients. \nLearning Objectives: \n\nIdentify unique management considerations in the transition to adult care for patients with childhood-onset IEMs\nDistinguish adult-onset IEMs from classic presentations and discuss associated challenges in diagnosis and management\nOutline future directions for the advancement of care in adults with IEMs\n\n\n  \nSpeaker: Eliza Phillips\nBio:\nEliza Phillips is a clinical geneticist and metabolic physician working at the Alberta Children’s Hospital in Calgary\, Alberta. She\nrecently completed her medical genetics residency at the University of Calgary\, and hasdeveloped particular interests in adult\nmetabolics and medical education. \n  \nDates \nSeptember 16 – UBC\nOctober 14 – TBD\nNovember 18 – TBD\nDecember 16 – Ottawa\nJanuary 20 – Calgary\nFebruary 17 – McGill\nMarch 17 – TBD\nApril 14 – Toronto\nMay 19 – Manitoba\nJune 16 – Montreal \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-january-2023/
CATEGORIES:TeleGraf
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230113T130000
DTEND;TZID=America/Toronto:20230113T140000
DTSTAMP:20260626T174140
CREATED:20221202T182219Z
LAST-MODIFIED:20221202T182309Z
UID:10000019-1673614800-1673618400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:CCMG Webinar - Exploring "hidden" Genomic Variation In Rare Diseases: Application Of Long-read Genomic Sequencing In The Care4rare Solve Research Project
DESCRIPTION:Presented by PacBio \nDescription:\nIn this session we will discuss long-read genome sequencing and its applications in human rare genetic diseases. We will introduce the Care4Rare-SOLVE project\, provide insights from the application of long-read genome sequencing to study unsolved rare diseases in the context of our Canadian cohort\, and discuss the challenges and opportunities of adding new genomic technologies to our molecular toolbelt for rare disease research. \nSpeaker: Dr. Kym Boycott \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/ccmg-webinar-exploring-hidden-genomic-variation-in-rare-diseases-application-of-long-read-genomic-sequencing-in-the-care4rare-solve-research-project/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221216T123000
DTEND;TZID=America/Toronto:20221216T133000
DTSTAMP:20260626T174140
CREATED:20220902T211245Z
LAST-MODIFIED:20221206T204803Z
UID:10000017-1671193800-1671197400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG - The Leading Strand Series December 2022
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nOverview of Diversity in Genomics Research and Medicine\nThis talk will provide an overview of diversity in genomics research and medicine\, including representation from different social and cultural groups. We will discuss the history and definitions of “race”\, “ethnicity”\, and “ancestry” as well as their current uses in genetics and genomic medicine. Audience members will reflect on their own work and deliberate best practices related to the use of population descriptors as categorical variables.\n\nLearning Objectives – by the end of this session\, attendees will be able to:\n\n\nIdentify conceptual issues related to the use of categorical population descriptors in genetics and genomic medicine.\nAssess current practices in clinical genetics research and medicine around the use of race\, ethnicity\, and ancestry.\nDecide on appropriate and inappropriate applications of population descriptors in future work.\n\n\nAlice Popejoy\, Epidemiology \n  \nSpeaker:\nDr. Alice Popejoy \nBio\nAlice Popejoy\, Ph.D. is an Assistant Professor in the Epidemiology Division of the Department of Public Health Sciences at the University of California\, Davis (UC Davis Health). She is also an Associate Member of the UC Davis Comprehensive Cancer Center. Dr. Popejoy’s research program in public health genetics is situated at the intersections of evolutionary genomics\, biomedical data science\, statistical genetics\, and the attending ethical\, legal\, and social implications (ELSI). She is currently focused on innovation and methods development to fundamentally shift the way human populations are categorized in biomedical research\, epidemiology\, and precision medicine. She received her B.A. from Hamilton College and her Ph.D. in public health genetics from the University of Washington. \n  \n  \nDates \nSeptember 23\nOctober 28\nNovember 25\nDecember 16\nJanuary 27\nFebruary 24\nMarch 31\nApril 28\nMay 26\nJune 30 \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-december-2022/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221202T120000
DTEND;TZID=America/Toronto:20221202T130000
DTSTAMP:20260626T174140
CREATED:20221115T144406Z
LAST-MODIFIED:20221115T144406Z
UID:10000018-1669982400-1669986000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:CCMG Webinar - The Importance Of Tailored Approaches For Challenging Genomic Regions: Diagnostic Challenges In Cystic Kidney Disease
DESCRIPTION:Presented by Blueprint Genetics \nDescription:\nIn this webinar\, we will review the genetics of cystic kidney disease and the importance of genetic testing in this area. We will also report on our internal experience testing for cystic kidney disease and discuss the value of tailored approaches for clinically relevant but hard-to-sequence regions of the genome. \nSpeaker: Christèle du Souich \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/ccmg-webinar-the-importance-of-tailored-approaches-for-challenging-genomic-regions-diagnostic-challenges-in-cystic-kidney-disease/
CATEGORIES:Sponsored Education Sessions
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221125T120000
DTEND;TZID=America/Toronto:20221125T130000
DTSTAMP:20260626T174140
CREATED:20220902T210407Z
LAST-MODIFIED:20221117T215238Z
UID:10000010-1669377600-1669381200@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG - The Leading Strand Series November 2022
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nDates \nSeptember 23\nOctober 28\nNovember 25\nDecember 16\nJanuary 27\nFebruary 24\nMarch 31\nApril 28\nMay 26\nJune 30 \nClick HERE to register. \n  \nTitle: Hereditary Cancer Surveillance Using Cell-Free DNA Sequencing \nCarriers of hereditary cancer syndromes are at heightened risk for malignancy and therefore undergo annual clinical screening for a host of cancers. As cancers are now well-known to shed cell-free DNA into the blood stream\, we founded the CHARM consortium (Cell-free DNA in Hereditary and High-risk Malignancies\, www.charmconsortium.ca) to assess whether regular genome and methylome profiling of blood plasma can detect the earliest cancers in this population. In this talk\, I will discuss findings from multiple different types of hereditary cancer syndromes utilizing a combination of mutational\, fragmentomic\, and epigenetic approaches to cell-free DNA analysis. I will also introduce data sharing and analytic strategies to increase the sensitivity and impact of these techniques. I will also provide an update on the current activities and future directions of the CHARM consortium. \nLearning objectives: \n\nUnderstand some of the challenges with the collection\, generation\, and interpretation of liquid biopsy data in clinical studies.\nDescribe different biological aspects of cell-free DNA and associated technologies to detect early cancer.\nIdentify opportunities in hereditary cancer to assess the use of cell-free DNA sequencing technologies for cancer screening.\n\n \nDr. Trevor Pugh PhD\, FACMG \nBio \nDr. Trevor Pugh\, PhD\, FACMG is a cancer genomics researcher\, board-certified molecular geneticist\, and holder of the Canada Research Chair in Translational Genomics. He is Director of the Joint Genomics Program of the University Health Network and Ontario Institute for Cancer Research which delivers basic\, translational\, and clinically-accredited genomics services. He is also appointed as Associate Professor in the\nUniversity of Toronto Department of Medical Biophysics\, Senior Scientist at the Princess Margaret Cancer Centre\, and Senior Investigator at the Ontario Institute for Cancer Research. His research lab is focused on understanding clinical implications of clonal shifts in cancer and non-cancerous cell populations during treatment\, most recently using cell-free DNA\, immune repertoire\, and single cell RNA-seq sequencing.\nMost recently\, he was recognized by Canada’s Top 40 Under 40\, the Canadian Cancer Society Bernard and Francine Dorval Prize\, a Terry Fox New Investigator Award\, and inclusion on the Web of Science Highly Cited Researchers List (top 1% of citations by field internationally).
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-november-2022/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221028T120000
DTEND;TZID=America/Toronto:20221028T130000
DTSTAMP:20260626T174140
CREATED:20220902T210306Z
LAST-MODIFIED:20221019T213712Z
UID:10000009-1666958400-1666962000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG - The Leading Strand Series October 2022
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \n \nOctober 28 – RNA Sequencing In The Clinical Laboratory: The Sickkids Experience\nIn recent years\, the use of next-generation sequencing (NGS) and the ability to sequence the entire genome has increased the diagnostic rate for both rare diseases and cancer. However\, despite rapid advances in our understanding of the human genome\, nearly two-thirds of the patients with suspected rare genetic disorders remain without a conclusive molecular genetic diagnosis. RNA sequencing has the potential to improve our ability to interpret the functional and clinical significance of the genetic variants. We will review the role of RNA sequencing in a number of clinical scenarios and the path to developing and integrating innovative whole transcriptome analysis in clinical diagnostics. \nLearning objectives:\nDescribe the path to developing and implementing RNA sequencing in the clinical laboratory\nIdentify current and future clinical applications of RNA sequencing \nTarget audience: Geneticists\, Trainees\nCanMEDS Roles: Medical Expert (the integrating role)\, Collaborator\, Health Advocate\, Scholar\, Professional \n  \nBio\nDr. Lianna Kyriakopoulou is currently a director of Genome Diagnostics at the Hospital for Sick Children and Assistant Professor at the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She received her PhD in Microbiology and Molecular and Medical Genetics from the University of Toronto. She is certified by the Canadian Academy of Clinical Biochemistry and the American College of Medical Genetics in Clinical Molecular Genetics. Dr. Kyriakopoulou’s professional interests are in the areas of genetic metabolic disorders and diagnostic assay development using high-throughput methodologies and genomic tests\, particularly for rare disorders. \nAll Dates \nSeptember 23\nOctober 28\nNovember 25\nDecember 16\nJanuary 27\nFebruary 24\nMarch 31\nApril 28\nMay 26\nJune 30 \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-october-2022/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221021T110000
DTEND;TZID=America/Toronto:20221021T120000
DTSTAMP:20260626T174140
CREATED:20220902T204621Z
LAST-MODIFIED:20221020T130717Z
UID:10000002-1666350000-1666353600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf October 2022
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nDr. Jessica Zambonin\nEmerging therapeutics for the treatment of Angelman syndrome\nObjectives:\n• Describe the clinical presentation Angelman syndrome and genetic mechanisms leading to the condition\n• Discuss approach to treatment of rare monogenic diseases based on disease mechanism\n• Review emerging gene therapy approaches to Angelman syndrome \nTarget audience: Trainees\nCanMEDS Roles: Medical Expert (the integrating role)\, Health Advocate\, Professional \nBio\nDr. Jessica Zambonin is a clinical geneticist working at the Provincial Medical Genetics Program in Vancouver BC. I am involved in the Angelman Syndrome Clinic at BC Children’s Hospital in collaboration with the Division of Neurology. We are currently part of the Angelman Syndrome Natural History Study based out of Boston Children’s Hospital and are working towards implementing gene therapy in our clinic. \nDates \nOctober 21 – UBC\nNovember 18 – TBD\nDecember 16 – Ottawa\nJanuary 20 – Calgary\nFebruary 17 – McGill\nMarch 17 – TBD\nApril 14 – Toronto\nMay 19 – Manitoba\nJune 16 – Montreal \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-october-2022/
CATEGORIES:TeleGraf
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220923T120000
DTEND;TZID=America/Toronto:20220923T130000
DTSTAMP:20260626T174140
CREATED:20220902T210107Z
LAST-MODIFIED:20220920T205745Z
UID:10000008-1663934400-1663938000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG - The Leading Strand Series September 2022
DESCRIPTION:Seeking Equity For Precision Diagnosis Through The Silent Genome Project-governance\, Diagnostic And Bioinformatic Highlights With The Introduction Of Cafe (cohort Allele Frequency Estimation Pipeline). \nSummary:\nDrs Arbour and Wasserman will provide an overview of the progress of Silent Genomes Project to date including governance\, diagnostic and bioinformatic highlights on the path to build a sustainable Indigenous Background Variant Library. \nObjectives: \n\nIdentify on-going barriers to achieving equitable genetics/genomics care for Indigenous patients.\nDescribe challenges and potential solutions presented through the Silent Genome Project to provide equitable precision diagnosis for Indigenous patients.\nLearn about a protected\, sustainable solution to housing Indigenous specific genomic reference data in Canada.\n\nThis series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nDates \nSeptember 23\nOctober 28\nNovember 25\nDecember 16\nJanuary 27\nFebruary 24\nMarch 31\nApril 28\nMay 26\nJune 30 \nClick HERE to register. \nSpeaker bios \nDr. Laura Arbour is a Professor in the Department of Medical Genetics at the University of British Columbia\, situated at the Island Medical Program on Vancouver Island. Trained as both pediatrician and clinical geneticist (McGill University) her multifaceted Community Genetics Research Program addresses rare\, single gene disorders and complex conditions affecting Indigenous people. Her clinical practice encompasses rare genetic disease diagnosis and cardio-genetics. Her Northern BC work on Long QT syndrome led to the development of the BC Inherited Arrhythmia Program (BCIAP) for all British Columbians with inherited arrhythmias. She is also the project lead on a Genome Canada/Genome BC/CIHR funded Large Scale Applied Research Project\, entitled “Silent Genomes: Reducing health-care disparities and improving diagnostic success for Indigenous children with genetic disease” which aims to address the challenges of equitable access to genetic/genomic diagnosis and care for Canadian Indigenous populations. \n A professor in the Department of Medical Genetics at the University of British Columbia and based at BC Children’s Hospital\, Dr. Wyeth Wasserman’s computational biology research focuses on the analysis of the human genome. His laboratory conducts research in two overlapping domains: the control of gene activity and the identification of the causes of rare genetic disorders. His lab created the JASPAR database and a wide range of software which are used globally to identify the “on/off” switches in genes. Since low-cost DNA sequencing became accessible for patients\, his team works closely with clinicians at BC Children’s Hospital to discover the genetic causes impacting patients and families. He is a co-lead for the Silent Genomes Project and the lead for Activity 3\, the Development of an Indigenous Background Variant Library.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-september-2022/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220606T080000
DTEND;TZID=UTC:20220610T170000
DTSTAMP:20260626T174140
CREATED:20220414T141204Z
LAST-MODIFIED:20220614T200109Z
UID:10000001-1654502400-1654880400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:CCMG 46th Annual Scientific Meeting
DESCRIPTION:We are pleased to launch an exciting program for the 46th CCMG annual scientific meeting\, highlighting innovative educational sessions and interactive social gathering opportunities. Registration will give full access to live meetings\, along with the option to access on-demand recordings of conferences following the events. \nPlease take note that the CCMG-CCGM annual general meeting will also take place virtually\, with details to come. \nPlease register online on our event website. \n\nCancellation Policy \nCancellation of registration must be received in writing at CCMG-CCGM Secretariat by June 1\, 2022 for registration fees to be refunded. \nA processing fee of $50 will be charged on all refunds.\nNo refunds will be issued after June 1\, 2022. \nRecording \nRecordings of all sessions will be available 1 week after the event and remain live for 3 weeks following. \nAccreditation \nThis event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada\, and approved by the Canadian Association of Pathology. \nCertificates of Participation \nWill be emailed automatically\, at the close of the event\, once the speaker evaluations are completed. There is no need to email and request a certificate unless you have not received the certificate within 2 weeks.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/ccmg-46th-annual-scientific-meeting/
CATEGORIES:Annual Scientific Meeting
ATTACH;FMTTYPE=image/jpeg:https://ccmg.51-222-78-205.ygkweb.ca/wp-content/uploads/2022/04/ccmg-event.jpg
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
LOCATION:
END:VEVENT
END:VCALENDAR